Side-to-side magnet anastomosis system duodeno-ileostomy with sleeve gastrectomy: early multi-center results.

"Declarations DisclosureMichel Gagner is a consultant with stock options in GT Metabolic Solutions, and is a consultant for Medtronic, Inc. and Lexington Medical, Inc. with stock options in Lexington Medical, Inc. Guy-Bernard Cadière is a consultant for GT Metabolic Solutions and member of the scientific advisory board without remuneration. Andres Sanchez-Pernaute is a consultant and received fees from Novo Nordisk, Medtronic, Johnson & Johnson, and Gore Medical. David Abuladze is a consultant for GT Metabolic Solutions without remuneration. Todd Krinke is an employee with GT patents and stock options. Jane Buchwald is a GT consultant with GT stock options; she received grants from Ethicon, Inc., M.I.D., Society of Bariatric and Metabolic Surgeons of Kazakhstan, Medical Faculty of Mannheim, Holy Family Hospital, Israel, and the American College of Surgeons. Nathalie Van Sante was an employee of GT Metabolic Solutions, Inc. during the study and drafting of the manuscript. Lamees Almutlaq holds stock options in GT Metabolic Solutions. Antonio Torres is a consultant for, and has received a grant from GT Metabolic Solutions. Marc Van Gossum, Jana Dziakova, Levan Koiava, Maja Odovic, and Mathilde Poras, have no potential conflicts of interest and nothing to disclose. Ethical approvalThe study was conducted in compliance with the registered Clinicaltrials.gov protocol (#NCT05322122) and in accord with the ethical standards of the institutional research committee, and with the 1964 Helsinki declaration and its later amendments, as well as with ISO14155 regulations, 21 CFR Parts 11, 50, 54, 56, and 812 Good Clinical Practices. Informed consentInformed Consent was obtained with adequate understanding and consent of participating patients. Disclosure Michel Gagner is a consultant with stock options in GT Metabolic Solutions, and is a consultant for Medtronic, Inc. and Lexington Medical, Inc. with stock options in Lexington Medical, Inc. Guy-Bernard Cadière is a consultant for GT Metabolic Solutions and member of the scientific advisory board without remuneration. Andres Sanchez-Pernaute is a consultant and received fees from Novo Nordisk, Medtronic, Johnson & Johnson, and Gore Medical. David Abuladze is a consultant for GT Metabolic Solutions without remuneration. Todd Krinke is an employee with GT patents and stock options. Jane Buchwald is a GT consultant with GT stock options; she received grants from Ethicon, Inc., M.I.D., Society of Bariatric and Metabolic Surgeons of Kazakhstan, Medical Faculty of Mannheim, Holy Family Hospital, Israel, and the American College of Surgeons. Nathalie Van Sante was an employee of GT Metabolic Solutions, Inc. during the study and drafting of the manuscript. Lamees Almutlaq holds stock options in GT Metabolic Solutions. Antonio Torres is a consultant for, and has received a grant from GT Metabolic Solutions. Marc Van Gossum, Jana Dziakova, Levan Koiava, Maja Odovic, and Mathilde Poras, have no potential conflicts of interest and nothing to disclose."

"Funding This study was supported by a research grant from GT Metabolic Solutions, Inc. (San Jose, CA)."

"Declarations: DisclosureMichel Gagner is a consultant with stock options in GT Metabolic Solutions, and is a consultant for Medtronic, Inc. and Lexington Medical, Inc. with stock options in Lexington Medical, Inc. Guy-Bernard Cadière is a consultant for GT Metabolic Solutions and member of the scientific advisory board without remuneration. Andres Sanchez-Pernaute is a consultant and received fees from Novo Nordisk, Medtronic, Johnson & Johnson, and Gore Medical. David Abuladze is a consultant for GT Metabolic Solutions without remuneration. Todd Krinke is an employee with GT patents and stock options. Jane Buchwald is a GT consultant with GT stock options; she received grants from Ethicon, Inc., M.I.D., Society of Bariatric and Metabolic Surgeons of Kazakhstan, Medical Faculty of Mannheim, Holy Family Hospital, Israel, and the American College of Surgeons. Nathalie Van Sante was an employee of GT Metabolic Solutions, Inc. during the study and drafting of the manuscript. Lamees Almutlaq holds stock options in GT Metabolic Solutions. Antonio Torres is a consultant for, and has received a grant from GT Metabolic Solutions. Marc Van Gossum, Jana Dziakova, Levan Koiava, Maja Odovic, and Mathilde Poras, have no potential conflicts of interest and nothing to disclose.: Ethical approvalThe study was conducted in compliance with the registered Clinicaltrials.gov protocol (#NCT05322122) and in accord with the ethical standards of the institutional research committee, and with the 1964 Helsinki declaration and its later amendments, as well as with ISO14155 regulations, 21 CFR Parts 11, 50, 54, 56, and 812 Good Clinical Practices.: Informed consentInformed Consent was obtained with adequate understanding and consent of participating patients. Ethical approval: The study was conducted in compliance with the registered Clinicaltrials.gov protocol (#NCT05322122) and in accord with the ethical standards of the institutional research committee, and with the 1964 Helsinki declaration and its later amendments, as well as with ISO14155 regulations, 21 CFR Parts 11, 50, 54, 56, and 812 Good Clinical Practices."